The potential use of lactate blockers for the prevention of COVID-19 worst outcome, insights from exercise immunology.
AbdelMassih AF, Menshawey R, Hozaien R, Kamel A, Mishriky F, Husseiny RJ, Hanoura AM, Yacoub E, AlShehry N, Menshawey E, El-Husseiny N, Yasser R, Arsanyous M, Nathan L, Seyam M, Massoud D, Ali N, Kassim A, AmanAllah M, Elsayed R, Sheashaa H, Husseiny Y, Hassan NH, Badr K, Elkhateb A, Fouad V, Elfishawy M, Medhat O, Mustafa M, Khalil N, Elsayed R, Nada Y, Elshawarbi P, Abdelmoneim N, Gamal N, Messiha M, Ghazy M, Abdelfatah E, Nasry F, Gayed R, Eesa M, Luis M, Eskandar E, Yacoub S, Saud A, Rajab M, Abdelaziz M, Elgamal N, Jaber H, Tayssir S, Michael M, Sabry A, Shehata J, Abdelaziz R, Rateb S, El-Maghraby A, Mahjoub Y, Amr A, Mabrouk A, Kelada P, Ragab S, Eltaher B, Hassan Galal R, Aly OM, Aly T, AbdelHaleem R, ElShaarawy A, Mohamed O.
AbdelMassih AF, et al. Among authors: amr a.
Med Hypotheses. 2021 Mar;148:110520. doi: 10.1016/j.mehy.2021.110520. Epub 2021 Jan 28.
Med Hypotheses. 2021.
PMID: 33561624
Free PMC article.
Review.
